Editor’s choice: Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know

This paper presents an update on diagnostic and prognostic biomarkers in malignant pleural mesothelioma considering also recent molecular biologic achievements as microRNA and genomic sequencing.